Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,581.60
+61.60 (2.44%)
Apr 17, 2025, 3:30 PM IST
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.07 trillion as of April 17, 2025. Its market cap has increased by 13.80% in one year.
Market Cap
1.07T
Enterprise Value
1.02T
Revenue
116.41B
Ranking
n/a
PE Ratio
50.81
Stock Price
2,581.60
Market Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.07T, an increase of 86.94%. That is a compound annual growth rate of 38.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 1,065.11B | -10.37% |
| Dec 31, 2024 | 1,188.36B | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,202.44B |
| Divi's Laboratories | 1,497.24B |
| Cipla | 1,223.70B |
| Apollo Hospitals Enterprise | 1,017.06B |
| Zydus Lifesciences | 836.73B |
| Aurobindo Pharma | 680.47B |
| Alkem Laboratories | 592.24B |
| Fortis Healthcare | 501.71B |